[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"histiocytosis-pulmonary\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:histiocytosis-pulmonary":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":5},"100413598","adult-pulmonary-langerhans-cell-histiocytosis-a-national-registry-based-prospective-cohort-study-100413598",false,"NCT04665674","Adult Pulmonary Langerhans Cell Histiocytosis: a National Registry-based Prospective Cohort Study","Enquête épidémiologique Sur la prévalence et le Pronostic de l'Histiocytose Langerhansienne Pulmonaire de l'Adulte en France","Inclusion Criteria:\n\n* Age \\>= 18 years\n* Diagnosis of PLCH was either histologically confirmed on a biopsy of an involved tissue, or based on the combination of the following criteria: 1) an appropriate clinical picture; 2) a typical nodulo-cystic pattern on lung high-resolution computed tomography (HRCT) and 3) exclusion of alternative diagnoses\n\nExclusion Criteria:\n\n\\-","ALL","18 Years",{"count":19,"type":20},500,"ESTIMATED","30 Years","OBSERVATIONAL","The long-term outcomes of adult patients with pulmonary Langerhans cell histiocytosis (PLCH), particularly survival, is largely unknown. This is the first prospective study in the field evaluating the long-term outcomes of PLCH patients. This french countrywide registry-based study included a large cohort of PLCH patients followed for a sufficiently long period to address risk factors of long-term outcomes of PLCH patients.",[25,26,27],"Histiocytosis","Histiocytosis, Langerhans-Cell","Histiocytosis Pulmonary","RECRUITING","2020-12-15",{"date":31,"type":32},"2020-12-17","ACTUAL",{"date":34,"type":32},"2004-01-01",{"date":36,"type":20},"2035-12-31",{"name":38,"class":39},"Assistance Publique - Hôpitaux de Paris","OTHER"]